June 30, 2020 / 5:10 AM / 13 days ago

BRIEF-Nordic Nanovector To Amend PARADIGME Trial Protocol

June 30 (Reuters) - Nordic Nanovector ASA:

* NORDIC NANOVECTOR TO AMEND PARADIGME TRIAL PROTOCOL TO EXPAND ELIGIBLE PATIENT POPULATION

* WILL AMEND TRIAL PROTOCOL FOR ITS PARADIGME TRIAL TO BROADEN INCLUSION CRITERIA AND EXPAND POOL OF ELIGIBLE PATIENTS WITH AIM OF INCREASING PRESENT RATE OF ENROLMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below